Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack (Q34592338)

3 August 2017

1 reference

title

Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack (English)

1 reference

3 August 2017

1 reference

Stephen Maher

1

1 reference

3 August 2017

Deirdre Toomey

series ordinal

2

1 reference

3 August 2017

Claire Condron

series ordinal

3

1 reference

3 August 2017

David Bouchier-Hayes

series ordinal

4

1 reference

3 August 2017

language of work or name

1 reference

1 April 2002

1 reference

Immunology & Cell Biology

3 August 2017

published in

1 reference

3 August 2017

volume

80

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

131-137

1 reference

Tyrosine kinase-dependent activation of a chloride channel in CD95-induced apoptosis in T lymphocytes.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Apoptosis by death factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Fas ligand mediates activation-induced cell death in human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Fas and FasL in the homeostatic regulation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Two CD95 (APO-1/Fas) signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Cytochrome c in the apoptotic and antioxidant cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

T-cell antigen receptor genes and T-cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Activation-induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Cutting Edge: The Tumor Counterattack Hypothesis Revisited: Colon Cancer Cells Do Not Induce T Cell Apoptosis Via the Fas (CD95, APO-1) Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Fas ligand-transfected myoblasts and islet cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Fas and Fas Ligand Expressed on Cells of the Immune System, not on the Target Tissue, Control Induction of Experimental Autoimmune Uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Countering the 'counterattack' hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Soluble Fas ligand and soluble Fas in ocular fluid of patients with uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Expression of Fas ligand in liver metastases of human colonic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Inverse relation of Fas-ligand and tumor-infiltrating lymphocytes in angiosarcoma: indications of apoptotic tumor counterattack.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

A modification of the JAM test is necessary for a correct determination of apoptosis induced by FasL adherent tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Gene transfer of Fas ligand induces tumor regression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

Regulation of the proinflammatory effects of Fas ligand (CD95L).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

A role for CD95 ligand in preventing graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1711.2002.01068.X

10.1046/J.1440-1711.2002.01068.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference